{"entity":{"type":"insider","cik":"0001636994","url":"/insider/0001636994","json_url":"/insider/0001636994.json","name":"Adams Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":63,"first":"2015-04-17","last":"2025-07-30","span_basis":"filed_date"},"name_variants":[{"name":"Adams Brian","source":"filing","n_filings":63,"first_seen":"2015-04-17","last_seen":"2025-07-30"}],"transactions":[{"id":4619626,"accession":"0000950170-25-100364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-100364","line_url":"/filing/0000950170-25-100364#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18276.0,"shares_display":"18,276","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":67255.68,"total_display":"67,255.68","total_whole":"67,256","shares_owned_after":371472.0,"shares_owned_after_display":"371,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-30","scope":"insider"},{"id":4619618,"accession":"0000950170-25-100364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-100364","line_url":"/filing/0000950170-25-100364#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1637.0,"shares_display":"1,637","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":6122.38,"total_display":"6,122.38","total_whole":"6,122","shares_owned_after":389748.0,"shares_owned_after_display":"389,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-30","scope":"insider"},{"id":4027553,"accession":"0000950170-25-061364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-061364","line_url":"/filing/0000950170-25-061364#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12943.0,"shares_display":"12,943","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":38829.0,"total_display":"38,829.00","total_whole":"38,829","shares_owned_after":391385.0,"shares_owned_after_display":"391,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-30","filed_date":"2025-04-30","scope":"insider"},{"id":4027552,"accession":"0000950170-25-061364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-061364","line_url":"/filing/0000950170-25-061364#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1644.0,"shares_display":"1,644","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":5211.48,"total_display":"5,211.48","total_whole":"5,211","shares_owned_after":404328.0,"shares_owned_after_display":"404,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-28","filed_date":"2025-04-30","scope":"insider"},{"id":4616961,"accession":"0000950170-25-047717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-047717","line_url":"/filing/0000950170-25-047717#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":298.0,"shares_display":"298","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":846.32,"total_display":"846.32","total_whole":"846","shares_owned_after":405972.0,"shares_owned_after_display":"405,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-03-31","scope":"insider"},{"id":4163345,"accession":"0000950170-25-011311","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-011311","line_url":"/filing/0000950170-25-011311#line-3","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20791.0,"shares_display":"20,791","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":91896.22,"total_display":"91,896.22","total_whole":"91,896","shares_owned_after":406270.0,"shares_owned_after_display":"406,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-30","scope":"insider"},{"id":4163341,"accession":"0000950170-25-011311","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-011311","line_url":"/filing/0000950170-25-011311#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33688.0,"shares_display":"33,688","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":155975.44,"total_display":"155,975.44","total_whole":"155,975","shares_owned_after":287920.0,"shares_owned_after_display":"287,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-30","scope":"insider"},{"id":2596003,"accession":"0000950170-24-141599","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-141599","line_url":"/filing/0000950170-24-141599#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":299.0,"shares_display":"299","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":1309.62,"total_display":"1,309.62","total_whole":"1,310","shares_owned_after":321608.0,"shares_owned_after_display":"321,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2024-12-31","scope":"insider"},{"id":2551079,"accession":"0000950170-24-118974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-118974","line_url":"/filing/0000950170-24-118974#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1632.0,"shares_display":"1,632","price_per_share":6.06,"price_display":"6.06","price_state":"stated","total_value":9889.92,"total_display":"9,889.92","total_whole":"9,890","shares_owned_after":321907.0,"shares_owned_after_display":"321,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-30","scope":"insider"},{"id":2206424,"accession":"0000950170-24-110804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-110804","line_url":"/filing/0000950170-24-110804#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295.0,"shares_display":"295","price_per_share":7.51,"price_display":"7.51","price_state":"stated","total_value":2215.45,"total_display":"2,215.45","total_whole":"2,215","shares_owned_after":323539.0,"shares_owned_after_display":"323,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-10-01","scope":"insider"},{"id":3074971,"accession":"0000950170-24-088811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-088811","line_url":"/filing/0000950170-24-088811#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1638.0,"shares_display":"1,638","price_per_share":8.85,"price_display":"8.85","price_state":"stated","total_value":14496.3,"total_display":"14,496.30","total_whole":"14,496","shares_owned_after":323834.0,"shares_owned_after_display":"323,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-29","filed_date":"2024-07-31","scope":"insider"},{"id":2589056,"accession":"0000950170-24-079684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-079684","line_url":"/filing/0000950170-24-079684#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295.0,"shares_display":"295","price_per_share":6.26,"price_display":"6.26","price_state":"stated","total_value":1846.7,"total_display":"1,846.70","total_whole":"1,847","shares_owned_after":325472.0,"shares_owned_after_display":"325,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-27","filed_date":"2024-07-01","scope":"insider"},{"id":3110080,"accession":"0000950170-24-050151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-050151","line_url":"/filing/0000950170-24-050151#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1623.0,"shares_display":"1,623","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":10354.74,"total_display":"10,354.74","total_whole":"10,355","shares_owned_after":325767.0,"shares_owned_after_display":"325,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-29","filed_date":"2024-04-29","scope":"insider"},{"id":2037123,"accession":"0000950170-24-038655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-038655","line_url":"/filing/0000950170-24-038655#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":348.0,"shares_display":"348","price_per_share":7.7,"price_display":"7.70","price_state":"stated","total_value":2679.6,"total_display":"2,679.60","total_whole":"2,680","shares_owned_after":327390.0,"shares_owned_after_display":"327,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-29","scope":"insider"},{"id":3076890,"accession":"0001209191-24-002468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002468","line_url":"/filing/0001209191-24-002468#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1929.0,"shares_display":"1,929","price_per_share":9.64,"price_display":"9.64","price_state":"stated","total_value":18595.56,"total_display":"18,595.56","total_whole":"18,596","shares_owned_after":327738.0,"shares_owned_after_display":"327,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":7924174,"accession":"0001209191-23-059991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059991","line_url":"/filing/0001209191-23-059991#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":11.51,"price_display":"11.51","price_state":"stated","total_value":3383.94,"total_display":"3,383.94","total_whole":"3,384","shares_owned_after":129667.0,"shares_owned_after_display":"129,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":8630768,"accession":"0001209191-23-054016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054016","line_url":"/filing/0001209191-23-054016#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1632.0,"shares_display":"1,632","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":9840.96,"total_display":"9,840.96","total_whole":"9,841","shares_owned_after":129961.0,"shares_owned_after_display":"129,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-11-01","scope":"insider"},{"id":8189925,"accession":"0001209191-23-050857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050857","line_url":"/filing/0001209191-23-050857#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":8.38,"price_display":"8.38","price_state":"stated","total_value":2463.72,"total_display":"2,463.72","total_whole":"2,464","shares_owned_after":131593.0,"shares_owned_after_display":"131,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8629853,"accession":"0001209191-23-043834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-043834","line_url":"/filing/0001209191-23-043834#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1628.0,"shares_display":"1,628","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":19210.4,"total_display":"19,210.40","total_whole":"19,210","shares_owned_after":131887.0,"shares_owned_after_display":"131,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-07-31","scope":"insider"},{"id":7835811,"accession":"0001209191-23-040054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040054","line_url":"/filing/0001209191-23-040054#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":12.12,"price_display":"12.12","price_state":"stated","total_value":3563.28,"total_display":"3,563.28","total_whole":"3,563","shares_owned_after":133515.0,"shares_owned_after_display":"133,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-28","scope":"insider"},{"id":9271995,"accession":"0001209191-23-033410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033410","line_url":"/filing/0001209191-23-033410#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1936.0,"shares_display":"1,936","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":21605.76,"total_display":"21,605.76","total_whole":"21,606","shares_owned_after":133809.0,"shares_owned_after_display":"133,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-06-01","scope":"insider"},{"id":8076599,"accession":"0001209191-23-026271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-026271","line_url":"/filing/0001209191-23-026271#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":863.0,"shares_display":"863","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":9631.08,"total_display":"9,631.08","total_whole":"9,631","shares_owned_after":134882.0,"shares_owned_after_display":"134,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-05-01","scope":"insider"},{"id":8072075,"accession":"0001209191-23-021414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021414","line_url":"/filing/0001209191-23-021414#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":347.0,"shares_display":"347","price_per_share":15.36,"price_display":"15.36","price_state":"stated","total_value":5329.92,"total_display":"5,329.92","total_whole":"5,330","shares_owned_after":135745.0,"shares_owned_after_display":"135,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-28","scope":"insider"},{"id":8542891,"accession":"0001209191-23-005687","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005687","line_url":"/filing/0001209191-23-005687#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":864.0,"shares_display":"864","price_per_share":21.56,"price_display":"21.56","price_state":"stated","total_value":18627.84,"total_display":"18,627.84","total_whole":"18,628","shares_owned_after":136092.0,"shares_owned_after_display":"136,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-01-31","scope":"insider"},{"id":8150910,"accession":"0001209191-23-003272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003272","line_url":"/filing/0001209191-23-003272#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9994.0,"shares_display":"9,994","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":199880.0,"total_display":"199,880.00","total_whole":"199,880","shares_owned_after":51531.0,"shares_owned_after_display":"51,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-13","scope":"insider"},{"id":6789119,"accession":"0001209191-22-062815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062815","line_url":"/filing/0001209191-22-062815#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295.0,"shares_display":"295","price_per_share":14.49,"price_display":"14.49","price_state":"stated","total_value":4274.55,"total_display":"4,274.55","total_whole":"4,275","shares_owned_after":61525.0,"shares_owned_after_display":"61,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-28","scope":"insider"},{"id":6730315,"accession":"0001209191-22-055112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055112","line_url":"/filing/0001209191-22-055112#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":728.0,"shares_display":"728","price_per_share":21.54,"price_display":"21.54","price_state":"stated","total_value":15681.12,"total_display":"15,681.12","total_whole":"15,681","shares_owned_after":61820.0,"shares_owned_after_display":"61,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-11-01","scope":"insider"},{"id":6893933,"accession":"0001209191-22-051539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051539","line_url":"/filing/0001209191-22-051539#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":22.73,"price_display":"22.73","price_state":"stated","total_value":6682.62,"total_display":"6,682.62","total_whole":"6,683","shares_owned_after":62548.0,"shares_owned_after_display":"62,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-29","scope":"insider"},{"id":6573972,"accession":"0001209191-22-043534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043534","line_url":"/filing/0001209191-22-043534#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":734.0,"shares_display":"734","price_per_share":21.27,"price_display":"21.27","price_state":"stated","total_value":15612.18,"total_display":"15,612.18","total_whole":"15,612","shares_owned_after":62842.0,"shares_owned_after_display":"62,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6547613,"accession":"0001209191-22-039656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-039656","line_url":"/filing/0001209191-22-039656#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":20.31,"price_display":"20.31","price_state":"stated","total_value":6093.0,"total_display":"6,093.00","total_whole":"6,093","shares_owned_after":63576.0,"shares_owned_after_display":"63,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-28","scope":"insider"},{"id":6727902,"accession":"0001209191-22-026520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-026520","line_url":"/filing/0001209191-22-026520#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":708.0,"shares_display":"708","price_per_share":25.57,"price_display":"25.57","price_state":"stated","total_value":18103.56,"total_display":"18,103.56","total_whole":"18,104","shares_owned_after":63876.0,"shares_owned_after_display":"63,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6543144,"accession":"0001209191-22-021814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021814","line_url":"/filing/0001209191-22-021814#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333.0,"shares_display":"333","price_per_share":29.87,"price_display":"29.87","price_state":"stated","total_value":9946.71,"total_display":"9,946.71","total_whole":"9,947","shares_owned_after":64584.0,"shares_owned_after_display":"64,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"},{"id":4493913,"accession":"0001209191-21-071308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-071308","line_url":"/filing/0001209191-21-071308#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295.0,"shares_display":"295","price_per_share":33.1,"price_display":"33.10","price_state":"stated","total_value":9764.5,"total_display":"9,764.50","total_whole":"9,765","shares_owned_after":24989.0,"shares_owned_after_display":"24,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-27","scope":"insider"},{"id":4237737,"accession":"0001209191-21-064872","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064872","line_url":"/filing/0001209191-21-064872#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":35.42,"price_display":"35.42","price_state":"stated","total_value":230230.0,"total_display":"230,230.00","total_whole":"230,230","shares_owned_after":25284.0,"shares_owned_after_display":"25,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-16","scope":"insider"},{"id":4435429,"accession":"0001209191-21-057858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057858","line_url":"/filing/0001209191-21-057858#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":293.0,"shares_display":"293","price_per_share":36.87,"price_display":"36.87","price_state":"stated","total_value":10802.91,"total_display":"10,802.91","total_whole":"10,803","shares_owned_after":25284.0,"shares_owned_after_display":"25,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-27","scope":"insider"},{"id":5478493,"accession":"0001209191-21-055784","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055784","line_url":"/filing/0001209191-21-055784#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":35.02,"price_display":"35.02","price_state":"stated","total_value":227630.0,"total_display":"227,630.00","total_whole":"227,630","shares_owned_after":25577.0,"shares_owned_after_display":"25,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-13","scope":"insider"},{"id":4484676,"accession":"0001209191-21-044065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-044065","line_url":"/filing/0001209191-21-044065#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":293.0,"shares_display":"293","price_per_share":35.81,"price_display":"35.81","price_state":"stated","total_value":10492.33,"total_display":"10,492.33","total_whole":"10,492","shares_owned_after":25577.0,"shares_owned_after_display":"25,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":5428760,"accession":"0001209191-21-039328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-039328","line_url":"/filing/0001209191-21-039328#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":227500.0,"total_display":"227,500.00","total_whole":"227,500","shares_owned_after":25870.0,"shares_owned_after_display":"25,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":5159066,"accession":"0001209191-21-028861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-028861","line_url":"/filing/0001209191-21-028861#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":227500.0,"total_display":"227,500.00","total_whole":"227,500","shares_owned_after":25870.0,"shares_owned_after_display":"25,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-26","filed_date":"2021-04-28","scope":"insider"},{"id":4087212,"accession":"0001209191-21-006365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-006365","line_url":"/filing/0001209191-21-006365#line-2","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":275250.0,"total_display":"275,250.00","total_whole":"275,250","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-28","filed_date":"2021-01-29","scope":"insider"},{"id":2169269,"accession":"0000899243-20-019840","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-019840","line_url":"/filing/0000899243-20-019840#line-1","is_derivative":false,"issuer_cik":"0001636994","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001636994","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-21","scope":"insider"},{"id":6333345,"accession":"0001114220-18-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000021","line_url":"/filing/0001114220-18-000021#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5652.0,"shares_display":"5,652","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":27186.12,"total_display":"27,186.12","total_whole":"27,186","shares_owned_after":126069.0,"shares_owned_after_display":"126,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-16","scope":"insider"},{"id":6605773,"accession":"0001114220-18-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000013","line_url":"/filing/0001114220-18-000013#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1541.0,"shares_display":"1,541","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":7412.21,"total_display":"7,412.21","total_whole":"7,412","shares_owned_after":131721.0,"shares_owned_after_display":"131,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-29","filed_date":"2018-01-31","scope":"insider"},{"id":6649177,"accession":"0001114220-18-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000004","line_url":"/filing/0001114220-18-000004#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":753.0,"shares_display":"753","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":3531.57,"total_display":"3,531.57","total_whole":"3,532","shares_owned_after":133262.0,"shares_owned_after_display":"133,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-08","scope":"insider"},{"id":5289199,"accession":"0001114220-17-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000039","line_url":"/filing/0001114220-17-000039#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":8472.15,"total_display":"8,472.15","total_whole":"8,472","shares_owned_after":134015.0,"shares_owned_after_display":"134,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-30","filed_date":"2017-10-31","scope":"insider"},{"id":5289196,"accession":"0001114220-17-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000032","line_url":"/filing/0001114220-17-000032#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":630.0,"shares_display":"630","price_per_share":7.19,"price_display":"7.19","price_state":"stated","total_value":4529.7,"total_display":"4,529.70","total_whole":"4,530","shares_owned_after":135420.0,"shares_owned_after_display":"135,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-05","filed_date":"2017-10-06","scope":"insider"},{"id":5167898,"accession":"0001114220-17-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000024","line_url":"/filing/0001114220-17-000024#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1445.0,"shares_display":"1,445","price_per_share":7.14,"price_display":"7.14","price_state":"stated","total_value":10317.3,"total_display":"10,317.30","total_whole":"10,317","shares_owned_after":136050.0,"shares_owned_after_display":"136,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-01","scope":"insider"},{"id":4100190,"accession":"0000899243-17-018004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-018004","line_url":"/filing/0000899243-17-018004#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":641.0,"shares_display":"641","price_per_share":7.67,"price_display":"7.67","price_state":"stated","total_value":4916.47,"total_display":"4,916.47","total_whole":"4,916","shares_owned_after":137495.0,"shares_owned_after_display":"137,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"},{"id":4646348,"accession":"0000899243-17-011609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-011609","line_url":"/filing/0000899243-17-011609#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1441.0,"shares_display":"1,441","price_per_share":5.97,"price_display":"5.97","price_state":"stated","total_value":8602.77,"total_display":"8,602.77","total_whole":"8,603","shares_owned_after":138136.0,"shares_owned_after_display":"138,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider"},{"id":4690615,"accession":"0000899243-17-010411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-010411","line_url":"/filing/0000899243-17-010411#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001636994","owner_name":"Adams Brian","owner_display_name":"Adams Brian","owner_url":"/insider/0001636994","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1090.0,"shares_display":"1,090","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":6267.5,"total_display":"6,267.50","total_whole":"6,268","shares_owned_after":139577.0,"shares_owned_after_display":"139,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-17","filed_date":"2017-04-18","scope":"insider"}],"collapsed":true,"next_cursor":"2017-04-17|4690615","ledger_fault":false,"count":{"value":67,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":66,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":67},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001812364","name":"Relay Therapeutics, Inc.","url":"/issuer/0001812364","role":"Officer (Chief Legal Officer)","n_filings":38,"first_seen":"2020-07-21","last_seen":"2025-07-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001114220","name":"KERYX BIOPHARMACEUTICALS INC","url":"/issuer/0001114220","role":"Officer (General Counsel and Secretary)","n_filings":25,"first_seen":"2015-04-17","last_seen":"2018-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001636994","retrieved_at":"2026-08-27T07:36:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}